The New Science of Neurodegeneration: What Ties Parkinson’s, Alzheimer’s & MS Together?, Ep. 77

What do Alzheimer’s, Parkinson’s, and Multiple Sclerosis truly have in common? In this documentary-style deep dive, Dr. Victoria Muñoz explores the groundbreaking science revealing that these three major neurological diseases—once thought to be entirely separate—actually share the same biological roots. From chronic neuroinflammation and mitochondrial dysfunction to protein misfolding, immune dysregulation, and gut–brain axis disruption, the newest research is uncovering a unifying story of how the brain breaks down… and how we may be able to prevent it. This episode features the powerful insights of neurologist Dr. Ray Dorsey, author of Ending Parkinson’s Disease, whose research warns that Parkinson’s is now the fastest-growing neurological disorder in the world—fueled not just by genetics, but by environmental toxins such as TCE, paraquat, and air pollution. His work links these exposures to the same inflammatory and mitochondrial pathways implicated in Alzheimer’s and MS, revealing a much broader neurological crisis. You’ll learn: 🔹 The shared mechanisms driving Alzheimer’s, Parkinson’s & MS 🔹 How microglia, inflammation, and mitochondrial collapse accelerate neurodegeneration 🔹 Why protein misfolding (amyloid, tau, alpha-synuclein) behaves similarly across diseases 🔹 How gut bacteria and the vagus nerve influence brain inflammation 🔹 Why Dr. Ray Dorsey believes Parkinson’s is largely preventable 🔹 How toxins like trichloroethylene (TCE) increase the risk of neurodegeneration 🔹 Emerging therapies, biomarkers, and lifestyle strategies that offer real hope 🔹 How early detection could change everything This is the new science of neurodegeneration—and the future of prevention, diagnosis, and treatment. 📣 If you found this video helpful... Please LIKE, SUBSCRIBE, and SHARE with anyone interested in brain health, functional medicine, longevity, or the science of neurodegenerative disease. To schedule a new patient visit with Dr. Munoz, CLICK HERE: http://drvictoriamunoz.com Or Call (480) 239-1193 To sign up with Fullscript for quality supplements, CLICK HERE: https://us.fullscript.com/welcome/vmu... To purchase a signed version of The PAIN Solution (book) by Dr. Munoz, CLICK HERE: https://drvictoriamunoz.com/the-pain-... Is Knee pain preventing you from participating in the activities that you love? Look no further. Dr. Munoz' personally designed knee brace will help. To learn more go to: https://drvictoriamunoz.com/power-kne... Find us on Instagram:   / precisionhealthperformance   References Cunnane, S. C., Courchesne-Loyer, A., Vandenberghe, C., St-Pierre, V., Pierotti, T., Fortier, M., & Castellano, C.-A. (2016). Can ketones compensate for deteriorating brain glucose uptake during aging? Implications for Alzheimer’s disease. Frontiers in Aging Neuroscience, 8, 54. Mahad, D. H., Trapp, B. D., & Lassmann, H. (2015). Pathological mechanisms in progressive multiple sclerosis. The Lancet Neurology, 14(2), 183–193. Mazmanian, S. K., Sampson, T. R., Debelius, J. W., & et al. (2016). Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson’s disease. Cell, 167(6), 1469–1480. Sulzer, D., Alcalay, R. N., Garretti, F., Cote, L., Kanter, E., Agin-Liebes, J., ... & Sette, A. (2017). T cells from patients with Parkinson’s disease recognize α-synuclein peptides. Nature, 546(7660), 656–661. Tanzi, R. E. (2012). The genetics of Alzheimer’s disease. Cold Spring Harbor Perspectives in Medicine, 2(10), a006296. Baranzini, S. E., & Oksenberg, J. R. (2017). The genetics of multiple sclerosis: From 0 to 200 in 50 years. Trends in Genetics, 33(12), 960–970. Heneka, M. T., Golenbock, D. T., & Latz, E. (2015). Innate immunity in Alzheimer’s disease. Nature Immunology, 16(3), 229–236. Liddelow, S. A., & Barres, B. A. (2017). Reactive astrocytes and neuroinflammation in neurodegenerative disease. Nature Reviews Neuroscience, 18(11), 694–705.